China Anlotinib Hydrochloride Market Analysis, Application & Forecast To 2021-2025
Submitted by James Grey | December 4, 2021, 07:44:16 | Business
Anlotinib hydrochloride is a novel small molecule multi-target tyrosine kinase inhibitor that effectively inhibits kinases like VEGFR, PDGFR, FGFR, and c-Kit with anti-tumor angiogenesis and tumor growth inhibition effects. The drug is a new Category 1.1 antitumor drug developed by the Chinese pharmaceutical company Nanjing Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Source: https://www.bharatbook.com/report/1058810/research-report-on-chinas-anlotinib-hydrochloride-market
